• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

E-钙黏蛋白在尿路上皮癌的浆细胞样、印戒细胞和微乳头状变异型中的表达:与普通型高级别尿路上皮癌的比较。

E-cadherin expression in plasmacytoid, signet ring cell and micropapillary variants of urothelial carcinoma: comparison with usual-type high-grade urothelial carcinoma.

机构信息

Department of Pathology, Emory University School of Medicine, Atlanta, GA, USA.

出版信息

Mod Pathol. 2011 Feb;24(2):241-7. doi: 10.1038/modpathol.2010.187. Epub 2010 Sep 3.

DOI:10.1038/modpathol.2010.187
PMID:20818341
Abstract

Loss of E-cadherin expression has been linked to the invasive phenotypes of a variety of neoplasms, including lobular breast cancer. The expression of E-cadherin in variants of urothelial carcinoma relative to usual-type urothelial carcinoma, maximum depth of invasion and angiolymphatic invasion has not been well characterized. A total of eight cases of micropapillary urothelial carcinoma, four cases of plasmacytoid urothelial carcinoma, two cases of urothelial carcinoma with signet ring cell differentiation and two cases of urothelial carcinoma with mixed plasmacytoid and signet ring cell differentiation, all obtained from cystectomy/cystoprostatectomy cases, were identified. In all nine cases of usual-type invasive and noninvasive high-grade urothelial carcinoma were also included in the study. Immunohistochemical staining of E-cadherin was performed in all cases. Pathological parameters including depth of invasion and presence of angiolymphatic invasion were documented. Maximum depth of invasion: In micropapillary urothelial carcinoma, extravesical extension was seen in three of eight cases; muscularis propria invasion in four of eight cases; and lamina propria invasion in one of eight cases. In plasmacytoid urothelial carcinoma, extravesical extension was observed in two of four cases, and muscularis propria invasion and lamina propria invasion in one of four cases each. In urothelial carcinoma with signet ring cell differentiation, extravesical extension and muscularis propria invasion was seen in one of two cases each. In urothelial carcinoma with mixed plasmacytoid and signet ring cell differentiation, muscularis propria invasion and lamina propria invasion was observed in one of two cases each. In usual-type high-grade urothelial carcinoma, extravesical extension was seen in six of nine cases and noninvasive in three of nine cases. In angiolymphatic invasion, micropapillary urothelial carcinoma was observed in eight of eight cases; plasmacytoid urothelial carcinoma in two of four cases; urothelial carcinoma with signet ring cell differentiation in one of two cases; and urothelial carcinoma with mixed plasmacytoid and signet ring cell differentiation in one of two cases. Usual-type high-grade urothelial carcinoma was seen in six of nine cases. E-cadherin expression: All eight cases of micropapillary urothelial carcinoma were positive for E-cadherin in the micropapillary component and adjacent usual-type urothelial carcinoma. The four cases of plasmacytoid urothelial carcinoma, two cases of urothelial carcinoma with signet ring cell differentiation and two cases of urothelial carcinoma with mixed plasmacytoid and signet ring cell differentiation were all negative for E-cadherin. All nine additional cases of usual-type high-grade urothelial carcinoma were diffusely positive for E-cadherin. E-cadherin is diffusely positive in usual-type urothelial carcinoma and micropapillary urothelial carcinoma, irrespective of pathological stage and angiolymphatic invasion. Loss of E-cadherin expression may be a marker of plasmacytoid and signet ring cell differentiation in urothelial carcinoma.

摘要

E-钙黏蛋白的表达缺失与多种肿瘤的侵袭表型有关,包括乳腺小叶癌。E-钙黏蛋白在膀胱癌中的变体相对于普通型膀胱癌、浸润深度和血管淋巴管侵犯的表达尚未得到很好的描述。总共鉴定了 8 例微乳头状尿路上皮癌、4 例浆细胞样尿路上皮癌、2 例具有印戒细胞分化的尿路上皮癌和 2 例具有混合浆细胞样和印戒细胞分化的尿路上皮癌,这些病例均来自膀胱切除术/膀胱前列腺切除术。在所有 9 例普通型浸润性和非浸润性高级别尿路上皮癌中也包括了研究。对所有 9 例病例均进行了 E-钙黏蛋白的免疫组织化学染色。记录了病理参数,包括浸润深度和血管淋巴管侵犯的存在。微乳头状尿路上皮癌中,8 例中有 3 例出现膀胱外扩展,8 例中有 4 例侵犯固有肌层,8 例中有 1 例侵犯固有层。浆细胞样尿路上皮癌中,4 例中有 2 例出现膀胱外扩展,4 例中有 1 例侵犯固有肌层和固有层。具有印戒细胞分化的尿路上皮癌中,2 例各有膀胱外扩展和固有肌层侵犯。具有混合浆细胞样和印戒细胞分化的尿路上皮癌中,2 例各有固有肌层侵犯和固有层侵犯。普通型高级别尿路上皮癌中,9 例中有 6 例出现膀胱外扩展,9 例中有 3 例为非浸润性。在血管淋巴管侵犯方面,8 例微乳头状尿路上皮癌、4 例浆细胞样尿路上皮癌、2 例具有印戒细胞分化的尿路上皮癌和 2 例具有混合浆细胞样和印戒细胞分化的尿路上皮癌中均观察到血管淋巴管侵犯。9 例普通型高级别尿路上皮癌中有 6 例出现血管淋巴管侵犯。E-钙黏蛋白表达:8 例微乳头状尿路上皮癌中,微乳头状成分和相邻的普通型尿路上皮癌均为 E-钙黏蛋白阳性。4 例浆细胞样尿路上皮癌、2 例具有印戒细胞分化的尿路上皮癌和 2 例具有混合浆细胞样和印戒细胞分化的尿路上皮癌均为 E-钙黏蛋白阴性。另外 9 例普通型高级别尿路上皮癌均为 E-钙黏蛋白弥漫阳性。E-钙黏蛋白在普通型尿路上皮癌和微乳头状尿路上皮癌中均为弥漫阳性,与病理分期和血管淋巴管侵犯无关。E-钙黏蛋白表达缺失可能是膀胱癌浆细胞样和印戒细胞分化的标志物。

相似文献

1
E-cadherin expression in plasmacytoid, signet ring cell and micropapillary variants of urothelial carcinoma: comparison with usual-type high-grade urothelial carcinoma.E-钙黏蛋白在尿路上皮癌的浆细胞样、印戒细胞和微乳头状变异型中的表达:与普通型高级别尿路上皮癌的比较。
Mod Pathol. 2011 Feb;24(2):241-7. doi: 10.1038/modpathol.2010.187. Epub 2010 Sep 3.
2
Human Epidermal Growth Factor Receptor 2 Overexpression in Micropapillary and Other Variants of Urothelial Carcinoma.人表皮生长因子受体 2 在微乳头状和其他变异型尿路上皮癌中的过表达。
Eur Urol Focus. 2018 Apr;4(3):399-404. doi: 10.1016/j.euf.2016.06.007. Epub 2016 Jun 21.
3
Transition between urothelial carcinoma in situ and non-invasive micropapillary carcinoma as a pivot connection between diverse morphologies of bladder carcinoma: a case report of urothelial carcinoma with villoglandular differentiation.原位尿路上皮癌与非浸润性微乳头癌之间的转变作为膀胱癌不同形态之间的关键联系:一例具有绒毛腺性分化的尿路上皮癌病例报告
Int J Clin Exp Pathol. 2015 Mar 1;8(3):3288-93. eCollection 2015.
4
[Plasmacytoid urothelial carcinoma of the urinary bladder: a clinicopathologic study of 16 cases].[膀胱浆细胞样尿路上皮癌:16例临床病理研究]
Zhonghua Bing Li Xue Za Zhi. 2013 Jul;42(7):433-7. doi: 10.3760/cma.j.issn.0529-5807.2013.07.001.
5
Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study.膀胱尿路上皮癌微乳头变型:一项临床病理及免疫组化研究
Histopathology. 2004 Jul;45(1):55-64. doi: 10.1111/j.1365-2559.2004.01895.x.
6
Urothelial carcinoma with villoglandular differentiation: a study of 14 cases.伴有绒毛腺性分化的尿路上皮癌:14例病例研究
Mod Pathol. 2009 Oct;22(10):1280-6. doi: 10.1038/modpathol.2009.97. Epub 2009 Jul 10.
7
Pleural fluid metastasis of plasmacytoid urothelial carcinoma in comparison to micropapillary and conventional high-grade urothelial carcinoma: Cytologic and immuonohistochemical findings.浆细胞样尿路上皮癌的胸腔积液转移与微乳头状和经典高级别尿路上皮癌的比较:细胞学和免疫组织化学表现。
Diagn Cytopathol. 2022 Sep;50(9):E248-E254. doi: 10.1002/dc.24975. Epub 2022 May 13.
8
Nuclear E-cadherin expression is associated with the loss of membranous E-cadherin, plasmacytoid differentiation and reduced overall survival in urothelial carcinoma of the bladder.核 E-钙黏蛋白表达与膜 E-钙黏蛋白的丢失、浆细胞样分化以及膀胱癌的总体生存时间缩短有关。
Ann Surg Oncol. 2013 Jul;20(7):2440-5. doi: 10.1245/s10434-012-2709-4. Epub 2012 Oct 30.
9
Non-invasive papillary urothelial carcinoma with 'micropapillary' architecture: clinicopathological study of 18 patients emphasising clinical outcomes.非浸润性乳头状尿路上皮癌伴“微乳头状”结构:强调临床转归的 18 例患者的临床病理研究。
Histopathology. 2020 Nov;77(5):728-733. doi: 10.1111/his.14161. Epub 2020 Sep 27.
10
High-grade urothelial carcinoma of the renal pelvis: clinicopathologic study of 108 cases with emphasis on unusual morphologic variants.肾盂高级别尿路上皮癌:108例临床病理研究,重点关注不寻常的形态学变异型
Mod Pathol. 2006 Apr;19(4):494-503. doi: 10.1038/modpathol.3800559.

引用本文的文献

1
Pitfalls of frozen section diagnosis in ureter margin evaluation of plasmacytoid urothelial carcinoma of urinary bladder.浆母细胞性尿路上皮膀胱癌输尿管切缘冰冻切片诊断的陷阱。
BMC Urol. 2024 Nov 16;24(1):254. doi: 10.1186/s12894-024-01643-0.
2
Plasmacytoid Variant Urothelial Cell Carcinoma: A Case of a Histological Variant of Urinary Bladder Cancer With Aggressive Behavior.浆细胞样变异型尿路上皮癌:1例具有侵袭性生物学行为的膀胱组织学变异型癌病例
Cureus. 2023 Mar 17;15(3):e36278. doi: 10.7759/cureus.36278. eCollection 2023 Mar.
3
Potential therapeutic targets discovery by transcriptome analysis of an in vitro human gastric signet ring carcinoma model.
通过体外人胃印戒细胞癌模型的转录组分析发现潜在的治疗靶点。
Gastric Cancer. 2022 Sep;25(5):862-878. doi: 10.1007/s10120-022-01307-8. Epub 2022 Jun 4.
4
Patient with prostatic adenocarcinoma with plasmacytoid features and an aberrant immunohistochemical phenotype diagnosed by biopsy and a mini-review of plasmacytoid features in the genitourinary system: A case report.经活检诊断为具有浆细胞样特征和异常免疫组化表型的前列腺腺癌患者及泌尿生殖系统浆细胞样特征的简要综述:病例报告
Mol Clin Oncol. 2022 Mar;16(3):67. doi: 10.3892/mco.2022.2500. Epub 2022 Jan 20.
5
Combination of histological and molecular data for improving outcome prediction in non-muscle invasive bladder cancer-narrative review.组织学和分子数据相结合以改善非肌层浸润性膀胱癌的预后预测——叙述性综述
Transl Cancer Res. 2020 Nov;9(11):7323-7336. doi: 10.21037/tcr-20-2257.
6
Cadherin Signaling in Cancer and Autoimmune Diseases.钙黏蛋白信号在癌症和自身免疫性疾病中的作用。
Int J Mol Sci. 2021 Dec 12;22(24):13358. doi: 10.3390/ijms222413358.
7
Clinicopathological characteristics and prognosis of signet ring cell carcinoma of the gallbladder.胆囊印戒细胞癌的临床病理特征和预后。
BMC Gastroenterol. 2021 Jun 6;21(1):248. doi: 10.1186/s12876-021-01831-4.
8
Clinicopathological characteristics and survival in lung signet ring cell carcinoma: a population-based study.肺印戒细胞癌的临床病理特征和生存:一项基于人群的研究。
Bosn J Basic Med Sci. 2021 Dec 1;21(6):752-759. doi: 10.17305/bjbms.2020.5454.
9
Expression of epithelial-Mesenchymal transition related markers in Plasmacytoid Urothelial carcinoma of the urinary bladder.膀胱浆细胞样尿路上皮癌中上皮-间充质转化相关标志物的表达。
BMC Urol. 2020 Jun 22;20(1):72. doi: 10.1186/s12894-020-00641-2.
10
Signet-Ring Cell Carcinoma as an Independent Prognostic Factor for Patients With Urinary Bladder Cancer: A Population-Based Study.印戒细胞癌作为膀胱癌患者的独立预后因素:一项基于人群的研究。
Front Oncol. 2020 May 15;10:653. doi: 10.3389/fonc.2020.00653. eCollection 2020.